AKT1 and hepatocellular carcinoma: In human HCC, AKT has been found to be activated in ~50% of tumor specimens, and is associated with aggressive tumor growth and poor prognosis.21, 22 Our recent and other studies demonstrate that an intact mTORC2 is required for the activation of AKT in vitro and in vivo.